HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-1.63%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.83B
AUM Growth
+$2.83B
(-7.7%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-6.59%
Top 10 Holdings %
Top 10 Hldgs %
54.57%
Holding
55
New
19
Increased
10
Reduced
13
Closed
12
Top Buys
| 1 |
Dentsply Sirona
XRAY
|
$145M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$103M |
| 3 |
Zimmer Biomet
ZBH
|
$87.2M |
| 4 |
Agilent Technologies
A
|
$70.5M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$68.3M |
Top Sells
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$202M |
| 2 |
Medtronic
MDT
|
$147M |
| 3 |
Incyte
INCY
|
$102M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$93.7M |
| 5 |
CELG
Celgene Corp
CELG
|
$93.1M |
Sector Composition
| 1 | Healthcare | 93.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cencora
COR
$56.5B
| $36.6M | 1.24% | +424,230 | New | +$36.6M |
|
27
Haemonetics
HAE
$2.63B
| $36.4M | 1.24% | 497,410 -952,590 | -66% | -$69.7M |
|
|
MDCO
28
DELISTED
Medicines Co
MDCO
| $32.5M | 1.1% | +985,222 | New | +$32.5M |
|
|
EVHC
29
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $31.3M | 1.07% | +814,840 | New | +$31.3M |
|
30
Acadia Pharmaceuticals
ACAD
$4.38B
| $31M | 1.05% | +1,378,000 | New | +$31M |
|
31
Avanos Medical
AVNS
$554M
| $28.9M | 0.98% | +627,500 | New | +$28.9M |
|
|
CVRS
32
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $27.4M | 0.93% | 19,981,655 | – | – |
|
33
Dynavax Technologies
DVAX
$1.19B
| $26.2M | 0.89% | +1,318,612 | New | +$26.2M |
|
34
Bio-Rad Laboratories Class A
BIO
$8.06B
| $25.7M | 0.88% | +102,940 | New | +$25.7M |
|
|
35
Vertex Pharmaceuticals
VRTX
$100B
| $24.4M | 0.83% | 149,790 -575,210 | -79% | -$93.7M |
|
36
Puma Biotechnology
PBYI
$254M
| $19.9M | 0.68% | +293,130 | New | +$19.9M |
|
37
Mettler-Toledo International
MTD
$26.8B
| $19.3M | 0.66% | +33,649 | New | +$19.3M |
|
|
XENT
38
DELISTED
Intersect ENT, Inc
XENT
| $18.3M | 0.62% | +464,850 | New | +$18.3M |
|
|
ACOR
39
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $18.2M | 0.62% | +769,601 | New | +$18.2M |
|
40
Boston Scientific
BSX
$156B
| $15.7M | 0.53% | 573,480 +205,648 | +56% | +$5.62M |
|
|
41
Incyte
INCY
$16.5B
| $10.9M | 0.37% | 130,910 -1,219,090 | -90% | -$102M |
|
|
42
Medtronic
MDT
$119B
| $9.56M | 0.33% | 119,120 -1,830,880 | -94% | -$147M |
|
|
ZSAN
43
DELISTED
Zosano Pharma Corporation
ZSAN
| $2.77M | 0.09% | +550,000 | New | +$2.77M |
|
44
Abbott
ABT
$231B
| – | – | -244,950 | Closed | -$14M |
|
45
CVS Health
CVS
$92.8B
| – | – | -1,125,000 | Closed | -$81.6M |
|
46
Humana
HUM
$36.5B
| – | – | -263,440 | Closed | -$65.4M |
|
47
Johnson & Johnson
JNJ
$427B
| – | – | -194,610 | Closed | -$27.2M |
|
48
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -1,309,960 | Closed | -$72.9M |
|
49
Stryker
SYK
$150B
| – | – | -166,280 | Closed | -$25.7M |
|
50
Tenet Healthcare
THC
$16.3B
| – | – | -2,956,351 | Closed | -$44.8M |
|